Joël Crouzet

Joël Crouzet is the CEO and Chairman at Ermium Therapeutics. Prior to this, they were an independent biotechnology consultant providing services on company development, R&D of biologicals, and more. Joël has also served on the board of directors for Biosupport and was the Chief Executive Officer for InnaVirVax. Under their leadership, InnaVirVax saw significant growth and progress, including the development of an innovative therapeutic HIV vaccine (VAC-3S) and the securing of over 16 M€ in funding.

Joël Crouzet has an educational background in entrepreneurship, strategy, and biotechnology. Joël has a PhD from AgroParisTech and is an engineer from the same school. Joël also has a degree in math, physics, and chemistry from Lycée Henri IV.

Some direct reports include Annegret Van Der Aa - CSO & CDO, Kristof Van Emelen - Head of Medicinal Chemistry.